AMYLOID CARDIOMYOPATHY
Clinical trials for AMYLOID CARDIOMYOPATHY explained in plain language.
Never miss a new study
Get alerted when new AMYLOID CARDIOMYOPATHY trials appear
Sign up with your email to follow new studies for AMYLOID CARDIOMYOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Breakthrough trial aims to stop devastating genetic disease before it starts
Prevention Recruiting nowThis study is testing whether a new drug called acoramidis can prevent or delay heart and nerve damage in people who carry a gene for a serious disease but don't yet have symptoms. About 582 adults aged 18-75 with the genetic risk will receive either the drug or a placebo to see …
Matched conditions: AMYLOID CARDIOMYOPATHY
Phase: PHASE3 • Sponsor: Eidos Therapeutics, a BridgeBio company • Aim: Prevention
Last updated Mar 23, 2026 15:15 UTC
-
Advanced scans aim to unlock secrets of heart disease
Knowledge-focused Recruiting nowThis study aims to improve how doctors tell apart different diseases that cause the heart muscle to thicken. Researchers will use detailed heart scans to look at blood flow patterns in 250 patients and their family members. The goal is to find unique 'fingerprints' for each disea…
Matched conditions: AMYLOID CARDIOMYOPATHY
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:40 UTC